uridine diphosphate n-acetylgalactosamine has been researched along with Brain Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arvanitis, TN; Griffin, JL; Kauppinen, RA; McConville, C; Mirbahai, L; Pan, X; Peet, AC; Wilson, M | 1 |
1 other study(ies) available for uridine diphosphate n-acetylgalactosamine and Brain Neoplasms
Article | Year |
---|---|
In vitro metabonomic study detects increases in UDP-GlcNAc and UDP-GalNAc, as early phase markers of cisplatin treatment response in brain tumor cells.
Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Brain Neoplasms; Cell Line, Tumor; Cisplatin; Humans; Magnetic Resonance Spectroscopy; Metabolomics; Monitoring, Physiologic; Prognosis; Rats; Uridine Diphosphate N-Acetylgalactosamine; Uridine Diphosphate N-Acetylglucosamine | 2011 |